The Current Dynamics in Capital Markets episode artwork

EPISODE · Apr 15, 2024 · 22 MIN

The Current Dynamics in Capital Markets

from Back Bay Life Science Report · host Jonathan P. Gertler, MD and Peter Bak, PhD

Welcome to another episode with the DNB//Back Bay Partnership for Healthcare.In this episode Jonathan Gertler, Back Bay CEO and Managing Partner, is once again joined by James Cirenza, Head of Fixed Income and Equities at DNB, Kristoffer Braaten, Director of US Equity Capital Markets at DNB, and Vasilios Kofitsas, Managing Director of Investment Banking at Back Bay Life Science Advisors, to talk about current market dynamics and the 2024 IPO outlook in the US and in Europe.Topics in this podcast include:Trends, cycles and the current state of capital markets in Europe and the USIPO performance for Q1 2024 vs. previous yearsTop characteristics of companies well-suited to go public and be successfulIPO market dynamics in Europe vs. the USExpectations and advice for companies contemplating going publicAs always we welcome listener questions and/or topics you’d like to learn more about.You can listen to previous episodes here or submit your inquiries to [email protected] more about the DNB//Back Bay Partnership and read our disclaimers at https://www.bblsa.com/dnb-back-bay-partnership.

Welcome to another episode with the DNB//Back Bay Partnership for Healthcare.In this episode Jonathan Gertler, Back Bay CEO and Managing Partner, is once again joined by James Cirenza, Head of Fixed Income and Equities at DNB, Kristoffer Braaten, Director of US Equity Capital Markets at DNB, and Vasilios Kofitsas, Managing Director of Investment Banking at Back Bay Life Science Advisors, to talk about current market dynamics and the 2024 IPO outlook in the US and in Europe.Topics in this podcast include:Trends, cycles and the current state of capital markets in Europe and the USIPO performance for Q1 2024 vs. previous yearsTop characteristics of companies well-suited to go public and be successfulIPO market dynamics in Europe vs. the USExpectations and advice for companies contemplating going publicAs always we welcome listener questions and/or topics you’d like to learn more about.You can listen to previous episodes here or submit your inquiries to [email protected] more about the DNB//Back Bay Partnership and read our disclaimers at https://www.bblsa.com/dnb-back-bay-partnership.

NOW PLAYING

The Current Dynamics in Capital Markets

0:00 22:25

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Back Bay Life Science Report?

This episode is 22 minutes long.

When was this Back Bay Life Science Report episode published?

This episode was published on April 15, 2024.

What is this episode about?

Welcome to another episode with the DNB//Back Bay Partnership for Healthcare.In this episode Jonathan Gertler, Back Bay CEO and Managing Partner, is once again joined by James Cirenza, Head of Fixed Income and Equities at DNB, Kristoffer Braaten,...

Can I download this Back Bay Life Science Report episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!